Percutaneous Closure of Window-Type Patent Ductus Arteriosus Using the CardioSEAL® and STARFlex® Devices
AUTOR(ES)
Bialkowski, Jacek
RESUMO
Transcatheter closure of patent ductus arteriosus is routinely performed using various devices. After the withdrawal of the Rashkind umbrella device from the market, the wide window-type patent ductus arteriosus has been difficult to close percutaneously. Two patients with this condition are presented: a 17-year-old man and a 62-year-old woman with short (4.5- and 5.2-mm-diameter, respectively) ductus. We successfully implanted a 17-mm CardioSEAL® device in the 1st patient and a 23-mm STARFle® in the 2nd, with no residual shunt at follow-up (22 and 8 months, respectively). Although these devices (which follow the general design of the Rashkind umbrella) are usually applied to atrial septal defect closure, we believe that CardioSEAL and STARFlex implants could be the treatment of choice in percutaneous treatment of window-type patent ductus arteriosus. (Tex Heart Inst J 2003;30:236–9)
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=197326Documentos Relacionados
- Drug induced closure of patent ductus arteriosus.
- Percutaneous closure of a post-traumatic ventricular septal defect with a patent ductus arteriosus occluder
- Chylothorax after closure of a patent ductus arteriosus.
- Sizing of Atrial Septal Defects to Predict Successful Closure with Transcatheter CardioSEAL™ Device
- Extrapleural Closure of Patent Ductus Arteriosus: How We Do It
